Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD
136.50
+0.50 (0.37%)
At close: Feb 13, 2026
HKG:2637 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
|---|
| 136.08 | 117.45 | 68.98 |
Depreciation & Amortization | 4.98 | 3.89 | 2.81 |
Loss (Gain) From Sale of Assets | - | 0.03 | 0.02 |
Loss (Gain) From Sale of Investments | -1.14 | - | 0.14 |
| 0 | 0.01 | 0.03 |
Provision & Write-off of Bad Debts | 0.13 | 0.67 | -0.06 |
Other Operating Activities | 15.4 | 23.24 | 29.24 |
Change in Accounts Receivable | -22.78 | -25.47 | 5.62 |
| -10.41 | 3.4 | -5.54 |
Change in Accounts Payable | 33.9 | 25.61 | -13.2 |
Change in Unearned Revenue | 7.78 | -1.72 | -2.73 |
| 163.94 | 147.11 | 85.31 |
Operating Cash Flow Growth | 11.45% | 72.44% | - |
| -178.56 | -58.71 | -3.07 |
Sale (Purchase) of Real Estate | - | -0.78 | -28.63 |
| -244.13 | 100.42 | -22.04 |
Other Investing Activities | 43.98 | -53.69 | -0.02 |
| -378.72 | -12.77 | -53.76 |
| 17.83 | 5.57 | - |
| -4.83 | -46.91 | -9.84 |
| 13 | -41.34 | -9.84 |
| - | - | 157.6 |
Other Financing Activities | -14.27 | -10.15 | -14.63 |
| -1.27 | -51.49 | 133.13 |
| -216.04 | 82.85 | 164.68 |
| -14.62 | 88.39 | 82.24 |
| - | 7.47% | - |
| -3.13% | 27.92% | 38.71% |
| -0.22 | 1.31 | 1.28 |
| 13.43 | 10.15 | 14.63 |
| 4.28 | 0.01 | - |
| -57.3 | 59.52 | - |
| -52.79 | 64.36 | - |
Change in Working Capital | 8.5 | 1.81 | -15.85 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.